GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Divi's Laboratories DIVISLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

11,565.50

+12.06%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹93.60bn

FY2016FY2025

Net income

₹21.91bn

FY2016FY2025

Free cash flow

₹2.15bn

FY2016FY2025

Shareholders' equity

₹149.69bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹93.60bn₹78.45bn₹77.68bn₹89.60bn₹69.69bn₹53.94bn₹49.46bn₹39.13bn₹41.06bn₹38.05bn
Gross profit₹50.12bn₹40.86bn₹40.79bn₹54.71bn₹42.19bn₹29.21bn₹27.86bn₹20.52bn₹22.57bn₹20.23bn
Research and development—————₹111.4m₹106.0m₹101.1m₹396.1m₹277.4m
Operating income₹25.70bn₹18.31bn₹20.26bn₹35.72bn₹26.15bn₹16.40bn₹17.06bn₹11.25bn₹13.63bn₹13.04bn
Net income₹21.91bn₹16.00bn₹18.23bn₹29.60bn₹19.84bn₹13.77bn₹13.53bn₹8.77bn₹10.60bn₹11.26bn
Diluted earnings per share82.6060.3168.76111.5274.7551.8650.9733.0439.9542.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹169.32bn₹154.70bn₹144.39bn₹133.75bn₹107.74bn₹85.36bn₹80.38bn₹67.86bn₹61.59bn₹49.02bn
Cash and short-term investments₹4.15bn₹3.63bn₹1.70bn₹12.15bn₹20.30bn₹10.14bn₹15.13bn₹20.01bn₹17.09bn—
Total liabilities₹19.63bn₹18.99bn₹16.72bn₹16.47bn₹14.79bn₹12.26bn₹10.81bn₹8.61bn₹8.01bn₹6.09bn
Debt₹40.0m₹20.0m₹27.7m₹28.7m₹40.4m₹381.0m₹1.06bn₹631.1m₹357.4m₹429.4m
Shareholders' equity₹149.69bn₹135.71bn₹127.67bn₹117.28bn₹92.95bn₹73.10bn₹69.57bn₹59.25bn₹53.57bn₹42.93bn
Shares outstanding265m265m265m265m265m265m265m265m265m265m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹16.53bn₹12.61bn₹24.60bn₹19.12bn₹19.47bn₹12.16bn₹9.54bn₹7.76bn₹11.50bn₹10.38bn
Capital spending−₹14.38bn−₹10.03bn−₹4.73bn−₹7.13bn−₹9.10bn−₹11.83bn−₹7.33bn−₹2.74bn−₹3.77bn−₹3.96bn
Free cash flow₹2.15bn₹2.58bn₹19.87bn₹11.99bn₹10.37bn₹327.3m₹2.21bn₹5.02bn₹7.74bn₹6.42bn
Dividends paid−₹7.96bn−₹7.96bn−₹7.96bn−₹5.31bn—−₹10.24bn−₹3.20bn−₹3.19bn—−₹6.39bn

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹26.04bn₹27.15bn₹24.10bn₹25.85bn₹23.19bn₹23.38bn₹21.18bn₹23.03bn
Gross profit₹16.59bn₹16.42bn₹14.54bn₹16.04bn₹13.97bn₹13.69bn₹12.65bn₹14.01bn
Operating income₹6.98bn₹7.75bn₹6.17bn₹7.79bn₹6.44bn₹6.17bn₹5.25bn₹6.38bn
Net income₹5.83bn₹6.89bn₹5.45bn₹6.62bn₹5.89bn₹5.10bn₹4.30bn₹5.38bn
Diluted earnings per share21.9825.9820.5524.9622.2019.2216.2020.24
Cash from operations—₹16.45bn—₹7.27bn—₹9.26bn—₹7.22bn
Capital spending—−₹15.44bn—−₹7.74bn—−₹6.64bn—−₹5.09bn
Free cash flow—₹1.01bn—−₹470.0m—₹2.62bn—₹2.13bn
Total assets—₹181.51bn—₹169.32bn—₹155.86bn—₹154.70bn
Cash and short-term investments—₹32.69bn—₹4.15bn—₹36.08bn—₹3.63bn
Debt—₹890.0m—₹40.0m—₹70.0m—₹20.0m
Shareholders' equity—₹154.13bn—₹149.69bn—₹137.17bn—₹135.71bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.5%11.7%11.7%
Operating income-10.4%9.4%9.5%
Net income-9.5%9.7%9.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.9%55.0%55.7%55.5%
Operating margin25.6%29.5%30.8%31.4%
Net margin22.0%25.3%25.8%26.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings77.5101.156.830.662.674.036.144.827.618.4
Price to sales18.120.613.310.117.818.99.910.17.15.5

Dividends and splits

Per share, in the currency the company pays

Paid for 23 years. Last went ex-dividend on 24 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2020FY2019FY2018
Paid in the year30.0030.0030.0030.0020.0032.0010.0010.00
  • 2-for-1 split · 23 Sept 2015
  • 2-for-1 split · 30 Jul 2009
  • 5-for-1 split · 3 Aug 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.